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globin RNA leader initiated inﬂuenza transcription compared to those with a single base-pairing possibility.
Altogether the results indicated an optimal cap donor consensus sequence of 7mG-(N)7–8-(A/U/G)-(A/U)-AGC-3′.elink).
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“Cap-snatching” is the transcription initiation mechanism found
among segmented negative (−) ssRNA viruses as ﬁrst described for
inﬂuenza A (Beaton and Krug, 1981; Bouloy et al., 1978; Caton and
Robertson, 1980; Dhar et al., 1980; Plotch et al., 1979, 1981). During this
process, the viral transcriptase cleavesm7G-cappedRNA leader sequences
from host mRNAs to prime transcription of the viral genome segments
(Fig. 1). The development of in vitro systems (Bouloy et al., 1978;Hagen et
al., 1994; Plotch et al., 1979) and reverse genetics approaches (Fodor et al.,
1999; Neumann et al., 1999; Pleschka et al., 1996) has advanced the
insight into cis- and trans-acting factors involved in cap-snatching.
The inﬂuenza heterotrimeric polymerase complex consists of
subunits, PB1, PB2 and PA. Whereas PB2 recognizes and binds to the
5′ cap structure of cellular mRNAs (Braam et al., 1983; Li et al., 2001),
PB1 has been thought to contain the active site of the polymerase
and to cleave bound capped RNAs at a site 10–13 nt downstream of
the cap (Li et al., 2001). The role of PA in viral transcription and
replication has long been unknown but recently the crystal structure
of the N-terminal domain of PA (PAN: residues 1–159) has been
determined (Yuan et al., 2009). This structure and the presence of a
bound magnesium ion by a motif similar to the (P)DXN(D/E)XK
motif characteristic of many endonucleases strongly suggests that
PAn holds the endonuclease activity rather than PB1 (Yuan et al.,
2009). Biochemical and structural studies have shown that theamino-terminal 209 residues of the PA contain the endonuclease
activity (Dias et al., 2009). Although several reports suggested that
speciﬁc base-pairing between multiple residues of the 5′- and 3′-
terminal end of the viral RNA (vRNA) template is required for
activation of the endonuclease (Cianci et al., 1995; Hagen et al.,
1994), others have suggested that the presence of the 5′-terminal
end of the vRNA template is sufﬁcient for cap-dependent endonu-
clease activity (Li et al., 2001).
For inﬂuenza A virus, a preference for purine at the 3′ end of the
donor leader has been proposed (Beaton and Krug, 1981; Plotch et al.,
1981), while only leaders harboring a 3′-terminal CA dinucleotide
would effectively be used as primers (Beaton and Krug, 1981; Rao et
al., 2003; Shaw and Lamb, 1984). For Bunyamwera and Dugbe virus
(family Bunyaviridae), a strong preference for cleavage after a U or C
residue, respectively, has been postulated (Jin and Elliott, 1993a,
1993b). In all these cases, however, conclusions were drawn from a
limited number of viral mRNAs produced in vivo and on basis of the
leader sequences only, while the origin of the selected leader and
further downstream sequences remained unknown. Hence, it cannot
be ruled out that these leaders had been cleaved 1–2 nt downstream
of the assumed 3′ end and prior to which base-pairing of residues
downstream of the snatched leader sequence assists in the alignment
of leader on the vRNA template to render a stabilized transcription
initiation complex. Indeed some in vitro studies on inﬂuenza A virus
support the idea of base-pairing during leader alignment on the viral
template (Chung et al., 1994; Hagen et al., 1994, 1995; Plotch et al.,
1981). Work by Chung et al. (1994) already showed the possibility of
RNA leaders to directly become elongated on the vRNA template,
without the need for additional cleavage. While the involvement of
base complementarity of these leaders to the vRNA template was not
Fig. 1. Schematic presentation of inﬂuenza virus genome transcription initiation.
Cleavage of a cellular mRNA and subsequent use of the capped RNA leader in priming
genome transcription is shown.
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their 3′ terminus with complementarity to the vRNA template to
immediately allow elongation without further cleavage. In another
study, Hagen et al. (1995) concluded that the endonuclease cleavage
site within an mRNA is completely controlled by the mRNA and does
not depend upon interactions with the vRNA template, though the site
of initiation is inﬂuenced by template–primer interactions. However,
a more detailed look at the altered cleavage sites within mutated
mRNA leader sequences shows that the altered cleavage sites vary
with the possibility to allow initiation/elongation after base-pairing of
the leader 3′ residues with the vRNA template. In addition to their
earlier observed requirement of a vRNA template (harboring the 5′
and 3′ termini) to activate endonuclease cleavage and transcription
(Hagen et al., 1994), these data support the idea that base-pairing
between nucleotide residues of the snatched leader sequence, and
residues further downstream, to the vRNA 3′ terminus may play an
important role during the alignment and subsequent endonuclease
cleavage.
On the other hand, some studies report cleavage without the
presence of the 3′ terminal sequence of the vRNA template and the
absence of any base complementarity of RNA leaders to the 3′ end of
the vRNA template (Krug et al., 1980; Rao et al., 2003). However, in
one of the latest cap-snatching models presented (Rao et al., 2003),
the possibility of base-pairing between the 3′ terminal A residue with
the terminal U of the 3′ end of the vRNA template was not excluded.
A “prime-and-realign”mechanism has been proposed for Hantaan
virus to account for the vRNA polymerase to initiate (anti)genome/
mRNA synthesis with GTP (Garcin et al., 1995), but a prime-and-
realign could also explain the presence of repetitive sequences
observed within the leader sequence of viral transcripts from other
viruses that apply cap-snatching (Bishop et al., 1983; Bouloy et al.,
1990; Duijsings et al., 2001; Garcin et al., 1995; Jin and Elliott, 1993b;
Simons and Pettersson, 1991; van Knippenberg et al., 2005), and
indicate the involvement of base-pairing between leader and
template.
Here we set out to analyze inﬂuenza A virus cap donor
requirements, and more speciﬁcally the possible role of base-pairing
between donor and template, during transcription initiation. To this
end, various Alfalfa mosaic virus RNA3 (AlMV3)-derived mutants
were tested as cap donors in pair-wise or multiple competitions using
an in vitro inﬂuenza A transcription system. The results show that base
complementarity to the viral genome template promotes the use of
capped leaders and that residues 5′ of the base-pairing residues are of
importance.
Results
Inﬂuenza A transcription in the presence of RRL
Prior to investigating cap donor requirements, an in vitro
transcription assay was established (Fig. 2A; Materials and methods),
in which puriﬁed inﬂuenza A virus particles support transcription. In
vitro reaction products from assays performed in the presence of
radionucleotides were resolved by RNA electrophoresis. The results
showed that puriﬁed virus particles supported the de novo synthesisof RNA molecules, but only in the presence of Rabbit Reticulocyte
Lysate (RRL) (Fig. 3A, lanes 1 and 2). Earlier, this was also observed for
several other (−) ssRNA viruses (Bellocq et al., 1987; Nguyen et al.,
1997; van Knippenberg et al., 2002; Vialat and Bouloy, 1992) in which
the requirement of RRL was explained to provide not only in a source
of capped RNAs but also factors needed to support in ongoing
transcription and prevent premature transcription termination.When
AlMV3 RNAs were used as primers for in vitro inﬂuenza transcription
in the absence of RRL, similar to earlier studies on several other (−)
ssRNA viruses (Bouloy et al., 1980; Li et al., 2001; Plotch et al., 1979,
1981; Robertson et al., 1980; van Knippenberg et al., 2002), no
transcriptional activity was observed (Fig. 3A, lane 4). The additional
increase of rNTP concentrations in the absence of RRL did not recover
inﬂuenza transcriptional activity either (data not shown). When in
addition to RRL, AlMV3 RNA was provided to the in vitro transcription
no further increase in transcriptional activity was observed in
comparison to the activity observed in the presence of RRL only
(Fig. 3A, lane 1 and 3). This was most likely due to the fact that
sufﬁcient globinmRNAmolecules were present in the RRL to supply in
a source of capped RNA for cleavage of 9–13 nt capped RNA leaders.
This was strengthened by the observation that the same RRL was
previously shown to provide sufﬁcient amounts of globin RNA for
cleavage of ~16 nt sized capped globin RNA leaders to initiate in vitro
genome transcription of the plant-infecting bunyavirus tomato
spotted wilt virus (TSWV, van Knippenberg et al., 2002), in which
additional AlMV RNA also did not further increase the yields of TSWV
transcription.
To verify that (some of) the de novo synthesized RNA molecules
were products of genuine transcriptional rather than replicational
activity, NS1 mRNA molecules from the in vitro reaction were RT-PCR
cloned and analyzed for their non-viral leader sequences. In view of
the expected short (9–13 nt) added leaders, a strategy using the
template-switch capacity of Superscript™ II RT was applied to amplify
de novo synthesized transcripts (Fig. 2B). Cloning and sequencing of
the products obtained (Fig. 3B, lane 1) revealed the presence of α- or
β-globin RNA leader sequences at the 5′ ends of NS1 transcripts,
snatched from globin mRNAs present in the RRL (Table 1), thus
conﬁrming the occurrence of in vitro transcription. Control reactions
using heat-inactivated virus never yielded any PCR product (Fig. 3B,
lane 2).
To test whether the established in vitro transcription systemwould
accept an exogenous source of capped RNA, AlMV3 RNAwas provided
to the in vitro transcription assay and de novo synthesized viral
transcripts RT-PCR cloned and analyzed for the presence of AlMV3
RNA leader sequences. Products of expected size were cloned and
sequenced and showed to consist of AlMV3 5′-terminal RNA leader
sequences, snatched from AlMV3 preceding the NS1 transcript. The
results thus showed that puriﬁed inﬂuenza particles were able to
cleave and use AlMV3 leaders during viral mRNA synthesis (Table 2b).
Base complementarity enhances cap donor preference, irrespective of a
cap-0 or cap-1 structure
Since exogenousAlMV3RNAwas shown tobe accepted as cap donor
in our in vitro inﬂuenza virus transcription assay, the in vitro assay was
next exploited to analyze whether base complementarity would
enhance cap donor selection. Four variant AlMV3 constructs
(Table 2a) differing in their complementarity to the 3′ end of the
vRNA templatewere tested inpair-wise competition. Theﬁrst construct,
i.e. wild type (WT), showed a single base complementarity to the vRNA
template (nucleotide A12), the second (denoted Mut-2) harbored 2
base-pairing residues (AG), the third (Mut-3) harbored 3 residues
(AGC) while the fourth construct (Mut-N14) reﬂected a genuine
inﬂuenza A transcript, i.e. a NP mRNA provided with a AlMV3 leader,
harboring 14 nt complementary to the NS1 vRNA template. To
discriminate between the WT and the three mutant sequences, a
Fig. 2. Schematic representation of the methodology. (A) In vitro inﬂuenza transcription assay and RT-PCR of de novo synthesized viral transcripts. As cap donors endogenous globin
mRNA or exogenously added AlMV3 transcripts are used. (B) Schematic procedure of RT-PCR ampliﬁcation of inﬂuenza viral transcripts harboring non-viral leader sequences, using
the template-switch methodology.
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respectively (Table 2a).
When WT and Mut-2 were added to the system, all cloned AlMV3-
NS1 transcript sequences contained marker nucleotide A (Table 2b),
indicative for the presence of the Mut-2 RNA leader sequence. Even
when Mut-2 was offered in a ratio 10 times less than WT (Table 2b), all
NS1 transcript clones, except of one which had a leader of unknown
origin, contained the Mut-2 leader sequence (Table 2b), indicating a
strongpreference forAlMV3Mut-2.Next,Mut-N14was tested alongwith
WT. When offered in 1:1 ratio (50 or 500 ng each), 35 out of 39 cloned
NS1 transcript sequences contained the marker nucleotide of Mut-N14.
When WT and Mut-N14 were offered in a 10:1 ratio, still 21 out of 25Fig. 3. Analysis of in vitro synthesized inﬂuenza mRNA. (A) In vitro transcription reactions usi
a 1% agarose gel and subsequently blotted to Hybond-N membrane. Lanes 1–4: Active virus.
not recover transcription. RNA size markers are indicated at the left. (B) RT-PCR analysis of
heat-inactivated virus (lane 2). Reverse transcription was performed using internal primer
gene in combination with a primer speciﬁc for the 5′ ﬁrst 11 nt of α-globin mRNA. M: molcontained the Mut-N14 leader. The origin of the leader sequence from 4
additional clones couldnotbe identiﬁeddue to theabsenceof themarker
nucleotide. The data obtained indicate that in vitro inﬂuenza prefers
leader sequences with increasing complementarity to the 3′ end of the
vRNA template. This was further strengthened by the performance of an
additional competition assay inwhichMut-2 andMut-3, only differing in
the complementarity to the vRNA template by one residue,was tested in
a pair-wise manner (Table 2b). When provided in equimolar amounts,
the Mut-3 leader was preferred, being used twice as often as the Mut-2
leader (Table2b). Surprisingly,whenMut-3andMut-N14wereoffered to
the in vitro transcription assay in various ratios, no clear preference for
the Mut-N14 leader was observed (Table 2b).ng [α-32P]CTP radiolabeled nucleotides in the presence/absence of RRL were resolved in
Lanes 5–6: heat-inactivated virus. In the absence of RRL, addition of AlMV3 leaders did
in vitro synthesized inﬂuenza mRNA in the presence of RRL, and active virus (lane 1) or
speciﬁc for the Inﬂuenza NS1 gene, followed by PCR using internal primer for the same
ecular marker.
Table 1
Distribution and nucleotide sequence of α- and β-globin leaders snatched from globin
messengers to prime virus NS1 mRNA transcription in vitro.
Capped leader Retrieved NS1 mRNA 5′ sequence # clones
α-Globina 5′-ACACUUCUGGUCCAGCAAAA 13
5′-ACACUUCUGGCAGCAAAA 1
5′-ACACUUCUGCAGCAAAA 2
β-Globinb 5′-ACACUUGCUUUUGAGCAAAA 1
5′-ACACUUGCUUUUGCAAAA 2
Viral sequence is underlined, while residues that possibly could originate from the globin
leader andwith complementarity to the vRNA template (3′-UCG…) are in bold and italics.
a α-Globin RNA sequence: 5′-ACACUUCUGGUCCAGUCCGA…3′.
b β-Globin RNA sequence: 5′-ACACUUGCUUUUGACACAAC…3′.
Table 2b
Distribution and nucleotide sequence of WT and/or mutant AlMV3 leaders snatched
during pair-wise competition to prime virus NS1 mRNA transcription in vitro.
Inﬂuenza sequence is underlined, while residues that possibly could originate from the
RNA leader offered and with complementarity to the vRNA template (3′-UCG…) are in
bold and italics; the marker nucleotide of each mutant is shaded.
Table 2c
Distribution and nucleotide sequence of leaders having a cap-0 or cap-1 structure
snatched during pair-wise competition to prime virus NS1 mRNA transcription in vitro.
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showed the presence of repetitive sequences in 9 clones, likely as a
result of prime-and-realign of capped leader sequences, indicating
again the occurrence of base-pairing during the transcription process.
Previously, the inﬂuence of different cap structures on inﬂuenza
transcription initiation in vitro was demonstrated suggesting a
preference for cap-1 structures (Bouloy et al., 1980). However, these
studies also showed that AlMV RNA leaders were relatively effective
primers for the polymerase reaction aswell. The high priming activity of
AlMVRNA appeared not to be due to the presence of cap-1 termini as, in
agreement with other reports (Pinck, 1975), only mono-methylated
cap-0 termini were detected. To rule out the possibility that the
presence of cap-0 structures at the 5′ endof AlMV3RNAaffected the use
of capped RNA leaders during cap donor competition assays, two pair-
wise competition assays were performed with Mut-2 andMut-3. In the
ﬁrst assay both leadermutantswere providedwith cap-0 structures and
in the second assay with cap-1 structures. After pair-wise competition
the results showed that, irrespective of the presence of a cap-0 or cap-1
structure, Mut-3 was clearly preferred (Table 2c) and being used twice
as often as Mut-2 as earlier observed (Table 2b). Altogether, these
results justiﬁed the further use of AlMV3 molecules to analyze leader
sequence requirements for inﬂuenza virus transcription initiation.
Inﬂuence of the 3′-terminal nucleotide of the leader
To analyzewhether the nucleotidewithin the sequence, upstreamof
the base-pairing residues affects leader preference, a second set of
AlMV3 leader constructs wasmade that harbored a C (WT), A, G or U at
position 11 and a single base-pairing residue A12 (Table 3a). Capped
transcripts of all four AlMV3 constructs were offered in equimolar
amounts to the in vitro assay. Surprisingly, 18 out of the 32 clones
analyzed contained aG at position 11 (Table 3b), indicating a preference
for the G11A12 sequence. However, 17 out of these 18 clones, lacked the
ﬁrst viral A residue, likely due to cleavage after G11 and internal priming
on the 3′-penultimate C residue of the viral template. Furthermore, 8 of
these leaders showed a repetitive sequence that probably resulted from
prime-and-realign. From the remaining 14 (out of 32) clones, 8 clonesTable 2a
Wild type (WT) and mutant AlMV3 leaders used in pair-wise or multiple competition
assays.
Residues potentially base-pairing to the viral template (3′-UCG…) are underlined; the
marker nucleotide used to discriminate between the different AlMV3 leaders is shaded.containedA11, 4 U11 and 2 C11. A closer look at the snatched leaders from
mutant A11A12 showed that 7 out of the 8 clones resulted from cleavage
downstreamA11 rather than A12, giving rise to a CA 3′ terminus. Only in
2 (out of 32) clones the leader originated from mutant C11A12, after
cleavage downstream of A12. Hence, although all 4 single base-pairingInﬂuenza sequence is underlined, while residues that possibly could originate from
the RNA leader offered and with complementarity to the vRNA template (3′-UCG…)
are in bold and italics; the marker nucleotide of each mutant is shaded.
Table 3a
Mutant AlMV3 leaders used in multiple competition assay.
Residues potentially base-pairing to the viral template (3′-UCG…) are underlined; the
marker nucleotide used to discriminate between the different AlMV3 leaders is shaded.
Table 4a
Mutant AlMV3 leaders used in multiple competition assay.
Residues potentially base-pairing to the viral template (3′-UCG…) are underlined; the
marker nucleotide used to discriminate between the different AlMV3 leaders is shaded.
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leaders harboring a 3′ CGA, primarily leading to internal priming, while
a 3′ CCA sequence was least preferred. Although explanations as an
alternative to the base-pairing hypothesis cannot be excluded, e.g.
cleavage after C10 and subsequent initiation on the 3′penultimate
residue in case of the 9 clones assigned toG11A12, such strategy does not
explain the presence of a (non-templated) U residue in 4 clones of
U12A12.
To determine which nucleotides at positions 10 (2 nt upstream the
base-pairing residues) and 11 would promote leader selection
without provoking internal priming, a next set of AlMV3 mutant
leaders wasmade, all harboring 3 base-pairing residues (AGC) at their
3′ end and variable residues at positions 10 or 11 (Tables 4a and 5a).
The resulting constructs were referred to as C10C11A12GC,
A10C11A12GC, G10C11A12GC and U10C11A12GC, and C11A12GC,
A11A12GC, G11A12GC and U11A12GC respectively. When all 4 leaders
differing in position 11 were offered in an equimolar mix, 19 out of 40
NS1 mRNA clones contained A11 and 15 U11 (Table 4b). Of the
remaining clones, 5 contained G11 and only 1 C11. Furthermore, in case
the leader originated from the G11-containing cap donor, internal
priming was only observed in 1 out of 5 clones. When G11 was offered
individually to the system, 5 out of 22 retrieved NS1 clones showed
the absence of the ﬁrst viral A residue, indicative for internal priming.
The lower frequency of internal primingwith G11A12GC in comparison
to G11A12 was likely due to the extra base-pairing residues present in
G11A12GC that apparently forced proper alignment along the 3′-
terminal residues of the vRNA template.
When all cap donor molecules harboring an altered nucleotide at
position 10 were simultaneously offered, no clear preference was
found, but C appeared to be inefﬁcient (Table 5b).Table 4b
Usage of RNA leaders with a mutation at position −1 relative to a triple base-pairing
A12GC residues snatched during a multiple competition to prime NS1 mRNAPair-wise competition between a singly and a triply base-pairing leader
with reciprocal 5′ upstream sequences
Based on the results above, single base-pairing AlMV3 leaders
harboring a 3′ AA were relatively favored but not those harboring a 3′
CA. To analyze whether this difference was also found in pair-wiseTable 3b
Usage of RNA leaders with a mutation at position −1 relative to a single base-pairing
A12 residue snatched during a multiple competition to prime NS1 mRNA transcription
in vitro.
Inﬂuenza sequence is underlined, while residues that possibly could originate from
the RNA leader offered and with complementarity to the vRNA template (3′-UCG…)
are in bold and italics; the marker nucleotide of each mutant is shaded.competitions among leaders with triple base-pairing possibilities,
thereby underscoring the importance of the nucleotide identity at
position 11, two additional competition experiments were performed.
In the ﬁrst one, leaders referred to as A11A12 and C11A12GC (Table 6a)
were tested and in the second one their reciprocal variants, C11A12
(identical to WT) and A11A12GC (Table 6a).
In theﬁrst case, 14 out of 18 clones analyzed contained a leader from
mutant C11A12GC and 4 fromA11A12 (Table 6b). In the second case, 18 of
the 19 clones contained the A11A12GC sequence and only one C11A12
(Table 6b). These results indicate that while nucleotide sequences
within the leader are of some importance, extending base complemen-
tary to the viral template is the predominant selective criterion.Leader length requirements for priming inﬂuenza transcription
Several publications indicate that the inﬂuenza transcriptase
generally cleaves at a position 9–15 nt downstream of the cap
(Bouloy et al., 1978; Plotch et al., 1979; Robertson et al., 1980). To
deﬁne the optimal leader length of a cap donor, AlMV3 leaders with
base-pairing residues at various positions relative to the 5′ cap were
made and tested. All constructs contained a CAGC sequence
embedded within an oligo U stretch, to guarantee proper alignment
of the leader along the vRNA template (Table 7a). The initial choice for
the CAGC context was made based on the earlier reported and
apparent preference of inﬂuenza virus for RNA leaders with a 3′-
terminal CA (Rao et al., 2003). Leader transcripts were simultaneously
offered in equimolar amounts. RT-PCR cloning and sequence analysis
of de novo synthesized viral transcripts revealed that 9 out of 17
transcripts contained capped leaders originating from C9A10GC, and 5
from C10A11GC (Table 7b), suggesting an optimal leader length of 10–
11 nt. Several clones revealed the presence of repetitive sequences,
again indicative for prime-and-realign.transcription in vitro.
Inﬂuenza sequence is underlined, while residues that possibly could originate from
the RNA leader offered and with complementarity to the vRNA template (3′-UCG…) are
in bold and italics; the marker nucleotide of each mutant is shaded.
Table 5a
Mutant AlMV3 leaders used in multiple competition assay.
Residues potentially base-pairing to the viral template (3′-UCG…) are underlined; the
marker nucleotide used to discriminate between the different AlMV3 leaders is shaded.
22 C. Geerts-Dimitriadou et al. / Virology 409 (2011) 17–26Reduced α-globin leader use in the presence of singly or triply base-pairing
cap donors
To analyze the potential competitor effect of singly and triply base-
pairing leaders on α-globin leader primed transcription, 3 leader
constructs (C11A12, C11A12GC and A11A12GC; Table 6a), were individ-
ually offered in various concentrations to the transcription assay.
These leaders differed in their base complementarity to the vRNA
template and/or one residue at position 11 just upstream the putative
base-pairing residue(s) of the leader sequence. Since the RRL lysate
used (AP-Biotech) had been treated with micrococcal nuclease by the
manufacturer the exact amounts of residual globin mRNAs molecules
as source for capped RNA leaders was unknown. As a consequence,
the reduction in globin leader initiated viral transcription by various
mutant AlMV3 leader RNAs would only provide a relative indicator on
the competitor effect of AlMV3 leaders. The relative reduction in α-
globin leader NS1 transcription initiation was analyzed by RT-PCR and
revealed that increasing amounts of C11A12 reduced globin leader
initiated NS1 transcription to a lesser extent than C11A12GC and
A11A12GC did (data not shown), in other words increasing comple-
mentarity of the AlMV3 leader sequence to the vRNA template
increased its use and strength as competitor.
To further quantify this effect, the AlMV3-NS1/α-globin-NS1 ratio
was determined by means of a two step quantitative real-time PCR
(see Materials and methods). A signiﬁcant, almost 3-fold increase of
the AlMV3-NS1/α-globin-NS1 ratio was observed when leader
A11A12GC was used compared to C11A12 (WT) (Fig. 4A; pair-wise t-
test on log transformed data, T2=−7.197, P=0.019). When all
leaders were compared, samples containing A11A12GC (with a triple
base complementarity and optimal A residue at position 11) gave the
highest AlMV3/α-globin-NS1 ratio, followed by C11A12GC (with a
triple base complementarity and a less optimal C residue at position
11) and then by C11A12 (with a single base complementarity and less
optimal C residue at position 11) (Fig. 4B). There was a signiﬁcant
effect of the leader used on the AlMV3/α-globin ratio (ANOVA on log
transformed data, F2,8=63.483, Pb0.001), and all three pair-wise
comparisons between the three leaders gave a signiﬁcant outcome
with a suitable post hoc test (Tukey HSD, Pb0.010 for all three
comparisons). When only inﬂuenza infected material was used asTable 5b
Usage of RNA leaders with a mutation at position −2 relative to a triple base-pairing A12G
in vitro.
Inﬂuenza sequence is underlined, while residues that possibly could originate from the RN
bold and italics; the marker nucleotide of each mutant is shaded.negative control, no viral NS1 transcripts containing cellular capped
leaders were PCR ampliﬁed with AlMV3 and NS1 primers (Fig. 4B).
Discussion
Although models for inﬂuenza are postulated as a paradigm for
cap-snatching by all segmented, (−) ssRNA viruses (Rao et al., 2003),
the matter of base-pairing between capped RNA leader and viral
template has remained unresolved. Here, it is shown that in vitro
inﬂuenza transcriptase selects donors with increasing base comple-
mentarity to the 3′-ultimate residues of the vRNA template (Tables 2a,
2b, 6a, and 6b). Competition experiments in which 2, 4 or even up to
11 capped leaders were offered indicated that this preference is
inﬂuenced, and even overruled when the base-pairing residues were
positioned in a less optimal distance to the 5′ cap, or when the
residues immediately 5′ of the base-pairing residues changed. Leaders
in which the ﬁrst base-pairing residue (A) was positioned 10 or 11 nt
downstream the cap were most favored (Tables 7a and 7b). When
alignment of the leader at the 3′-ultimate U residue of the vRNA
template occurred (e.g. forced by offering triple base-pairing leaders),
there was a preference for an A or U residue 5′ of the A12 base-pairing
residue (Tables 4a and 4b).
The presented data indicate that priming by virtue of base-pairing
is a preferred determinant for the selection of RNA leaders during
transcription initiation (Tables 2a–6b). During this process, base-
pairing most likely occurs before cleavage takes place, otherwise the
preference for extensive base complementarity cannot be explained.
In light of these observations, de novo synthesized viral transcripts
perfectly match the criteria for preferential use as cap donors.
However, selective protection of viral transcripts by the viral
polymerase has previously been demonstrated (Shih and Krug,
1996) and likely prevents a down regulation of viral transcription
due to re-snatching events of viral transcript leaders. The occurrence
of base-pairing prior to endonuclease cleavage is also supported by
the observation that elongation of short oligoribonucleotides can take
place after the ﬁrst, second or third base-pairing residue of the leader,
but not after a fourth. This implies that endonuclease cleavage can
take place after the ﬁrst base-pairing residues but not beyond the
third (Honda et al., 1986). In case of the latter, an additional cleavage
would be required to further trim the RNA leader sequence to render a
primer that can be elongated (Chung et al., 1994). The absence of a
clear viral preference for cap donors with either triple (Mut-3) or
multiple (Mut-N14) nucleotide complementarity to the vRNA tem-
plate would then suggest that residues further downstream of the
initial base-pairing ones do not play a major role anymore in the
alignment along the viral template.
In only 5 out of 397 cloned viral transcripts the marker nucleotide,
to discriminate between leader sequences, was lacking. The reason for
the absence of the marker nucleotide is not clear, but might be due to
sequencing error, or due to a transcription initiation event that did not
involve alignment of a capped RNA leader along the vRNA template byC residues snatched during a multiple competition to prime NS1 mRNA transcription
A leader offered and with complementarity to the vRNA template (3′-UCG…) are in
Table 7a
Mutant AlMV3 leaders used in multiple competition assays.
Residues potentially base-pairing to the viral template (3′-UCG…) are underlined; the
marker nucleotide used to discriminate between the different AlMV3 leaders is shaded.
Table 6a
WT and mutant AlMV3 leaders used in pair-wise competition assays.
Residues potentially base-pairing to the viral template (3′-UCG…) are underlined; the
marker nucleotide used to discriminate between the different AlMV3 leaders is shaded.
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viral transcripts without a marker nucleotide would strongly support
the importance of a base-pairing requirement of capped RNA leaders
during cap-snatching.
A total of 44 out of 397 cloned viral transcripts contained repetitive
sequences (GCAGC), indicating that prime-and-realign, as ﬁrst
described for Hantaan virus and later for transcription initiation of
other members of the Bunyaviridae and Arenaviridae (Bishop et al.,
1983; Bouloy et al., 1990; Duijsings et al., 1999, 2001; Garcin et al.,
1995; Jin and Elliott, 1993b; Simons and Pettersson, 1991; van
Knippenberg et al., 2005), also occurs with inﬂuenza virus. Although
prime-and-realign has never been observed during inﬂuenza tran-
scription, it recently has been reported during replication (Vreede et
al., 2008) where realignment was observed of a de novo synthesized
pppApG dinucleotide, templated by nucleotides 4 and 5 from the 3′
end of the complementary RNA (cRNA) template, to residues 1 and 2
to allow elongation to full-length vRNA.
Prime-and-realign is likely intrinsic to the mechanistic model of
cap-snatching in which primer alignment involves base-pairing. The
reason why some leaders appear to give rise to higher rates of prime-
and-realign than others remains unknown. Kawaguchi and Nagata
(2007) postulated that during replication of the inﬂuenza cRNA
strand, the vRNA polymerase converts from an initiating form that
holds the RNA weakly to an elongation form that holds the RNA
tightly. In light of these results, we speculate that a similar
phenomenon may occur during transcription initiation. During such
process, an apparent realignment occurs that in reality represents a
new initiation event involving an earlier aborted (weakly bound)
primer-initiation complex and resulting in the presence of a repetitive
sequence.
During in vitro inﬂuenza virus transcription in the presence of RRL,
globin messengers were used as cap donors, as expected. Previous
studies have reported that these molecules are good primers for
inﬂuenza virus transcription initiation (Bouloy et al., 1978; Plotch et
al., 1979, 1981; Robertson et al., 1980), and some have even suggested
β-globin leaders are more effective primers than α-globin (Bouloy etTable 6b
In vitro competition of a less preferred (CA) versus more preferred (AAGC) RNA leader
and their reciprocal leader variants during priming of NS1 mRNA transcription.
Inﬂuenza sequence is underlined, while residues that possibly could originate from
the RNA leader offered and with complementarity to the vRNA template (3′-UCG…)
are in bold and italics; the marker nucleotide of each mutant is shaded.al., 1978; Plotch et al., 1979). Considering that β-globin messengers
appear to bemore abundant in RRL thanα-globinmessengers (Bouloy
et al., 1978), the higher presence of α-globin leader sequences in viral
transcripts within a population of randomly cloned α- and β-globin
initiated inﬂuenza transcripts (16 out of 19; Table 1) was surprising
and suggests a preference for the α-globin leader. A further look at
both leader sequences revealed a higher base complementarity of the
α-globin, by the A14G15 dinucleotide, to the 3′-ultimate residues of
the inﬂuenza vRNA template compared to the β-globin leader that
only contained a single complementary nucleotide (A14). The
preferential use of α-globin leaders thus is in agreement with all
data from AlMV3 leader competition assays and altogether strongly
indicates that inﬂuenza virus displays a preference for capped RNA
leaders with increased base complementarity to the vRNA template.
The need for base complementarity between cellular leaders and
the viral template during inﬂuenza cap-snatching has been the source
of a long debate due to apparently conﬂicting data from many earlier
studies. Several in vitro studies (Chung et al., 1994; Hagen et al., 1994;
Plotch et al., 1981) showed that base-pair interactions can contribute
for alignment of the leader to the inﬂuenza vRNA template, which is
further supported by the ability of di- (ApG) and tri-nucleotides to
prime transcription in vitro (Honda et al., 1986). On the other hand,
capped ribopolymers lacking a sequence (AG or AGC) complementary
to the 3′ terminus of the vRNA (3′-UCGU) were still accepted as
primers for transcription, which led to the suggestion that base-pair
interactions are not required (Hagen et al., 1995; Krug et al., 1980).
Furthermore, in contrast to an earlier study (Rao et al., 2003), the
results presented here suggest that inﬂuenza does not effectively use
CA-terminating sequences as primers for in vitro transcription.Table 7b
Usage of RNA leaders varying in length from 7 to 17 nt relative to the position of base
complementarity (AGC) during priming of NP mRNA transcription.
Inﬂuenza sequence is underlined, while residues potentially base-pairing to the viral
template (3′-UCG…) are in bold and italics; the marker nucleotide used to discriminate
between the different AlMV3 leaders is shaded.
Fig. 4. Quantiﬁcation of AlMV3 and α-globin leader initiated NS1 transcription by two-step real-time PCR analysis. In vitro synthesized mRNA in the presence of RRL and addition of
AlMV3 leader, was reverse transcribed using an internal primer for Inﬂuenza NS1 gene. Quantitative real-time PCR ampliﬁcation was performed using a nested primer for the NS1
gene and a primer for the AlMV3 or α-globin mRNA. The geometric mean and standard error of the AlMV3/α-globin-NS1 ratio are given in both panels. (A) Active virus and
increasing concentrations of C11A12 (WT) or A11A12GC were used (concentrations are indicated in the X-axis). (B) Active virus and 0.5 μg of C11A12, C11A12GC or A11A12GC were used.
In the case of Control, no AlMV3 leader was offered.
24 C. Geerts-Dimitriadou et al. / Virology 409 (2011) 17–26The stronger in vitro reduction of α-globin RNA leader initiated
transcription by triply base-pairing cap donors compared to singly
base-pairing variants (Fig. 4) demonstrates the competitiveness of
such molecules during transcription initiation. Whether priming by
virtue of base-pairing also is a preferred determinant in vivo, remains
to be analyzed.
Materials and methods
Virus
Inﬂuenza virus strain A/Puerto Rico/8/34 (H1/N1) was propagated
and puriﬁed from embryonated chicken eggs. In brief, allantoic ﬂuid
was collected and cleared by low speed centrifugation for 10 min at
1000×g and ﬁltrated through a 0.45-μm-pore-size ﬁlter. The ﬁltrate
was layered onto 0.5 ml 60% (wt/vol) sucrose (in PBS)–2.0 ml 20%
(wt/vol) sucrose (in PBS) step gradients and centrifuged at
150,000×g for 2 h at 4 °C, using a SW41 rotor (Beckmann). Virus
particles were recovered from the interface, adjusted to 20% (wt/vol)
sucrose (in PBS), and loaded onto the top of a 12 ml 20% to 60% (wt/
vol) continuous sucrose gradient (in PBS). After centrifugation at
150,000×g for 16 h at 4 °C in a SW41 rotor (Beckmann), the virus
fraction was collected. Puriﬁed virus (10–15 μg/μl) was stocked in
small aliquots at −80 °C prior to use in transcription assays.
Construction of plasmids
AlMV3 constructs and WT were generated from plasmid pXO32N-
coP3, which contains a full length cDNA clone of AlMV3 (Neeleman et
al., 1993). WT, Mut-2 and Mut-3 were PCR ampliﬁed by using primer
AlMV3-Rv (complementary to nucleotides 339–313 of the AlMV3
sequence) and primers WT, Mut2 or Mut3 respectively. Mut-N14, an
AlMV3-inﬂuenza NP mutant which could base-pair over a stretch of
14 nt to the 3′ end of the viral NS1 template, was ampliﬁed with
primers MutN14 and NPUP2.
AlMV3 constructs that contained a point mutation at position 11 of
the AlMV3 sequence were made by ﬁrst amplifying pXO32NcoP3
using primers AlMV3-Rv and B11A (B=G, A or T). A second
ampliﬁcation was performed with primer T7prom1-AlMV3 for
extension of the AlMV3 leader with the T7 promoter sequence.
Point mutants of AlMV3 at nucleotide 11 are referred to as G11A12,
A11A12 and U11A12 (in which nucleotide at position 11 was changed
from C residue into a G, A or T respectively).Similarly, AlMV3 mutants that contained a mutation at either
position 10 or 11 of the AlMV3 sequence, and additionally the 3 base-
pairing residues (AGC) were made by ﬁrst ampliﬁcation of the same
plasmid with primers AlMV3-Rv and D10CAGC (D=C, G, A or T) or
E11AGC (E=C, G, A or T) respectively. Second ampliﬁcation was
performed with primer T7prom2-AlMV3 or T7prom1-AlMV3 for
AlMV3 constructs with mutation at position 10 or 11 respectively.
Point mutants of AlMV3 at 10 or 11 nt with the additional 3 base-
pairing residueswere referred to as G10C11A12GC (in which nucleotide
10 was changed from C into an G, and nucleotides at positions 13 and
14 into a G and C respectively), A10C11A12GC and U10C11A12GC or
G11A12GC, A11A12GC and U11A12GC respectively. C10C11A12GC and
C11A12GCweremade by changing the nucleotide U at positions 13 and
14 into a G and C respectively.
Ampliﬁed PCR fragments were separated by electrophoresis in a
1% agarose gel and puriﬁed using the GFX PCR puriﬁcation kit (Roche).
Puriﬁed products were restriction enzyme digested with BamHI/EcoRI
and ligated into pUC19 using T4 DNA ligase (Promega). The
nucleotide sequence of individual clones was veriﬁed by the
dideoxynucleotide chain termination method (Sanger et al., 1977)
using standard M13 sequencing primers and ultra-high throughput
(ABI Prism 3700) DNA sequencer (Greenomics™, Wageningen
University and Research Centre, The Netherlands).
Constructs for the leader length requirements experiment were
made by ﬁrst amplifying pXO32NcoP3 with primer AlMV3-Rv and
primers C7A8, C8A9, C9A10, C10A11, C11A12, C12A13, C13A14, C14A15,
C15A16, C16A17, or C17A18. Primer T7prom3-AlMV3 was used in the
second PCR ampliﬁcation. For these constructs, capped transcripts
were made directly from the puriﬁed PCR fragments without
additional cloning.
Primer sequences are listed in Supplementary Table 1.Synthesis of cap-0 and cap-1 RNA leaders
In vitro synthesis of capped RNA leaders was performed by using
the Ambion T7 mMESSAGE mMACHINE kit according to the
manufacturer's instruction. Transcription was performed in the
presence of cap-analog m7G5′ppp5′G. The cap analog/GTP ratio of
this solution is 4:1 and results in a 80% yield of capped transcripts. For
the cap-0 versus cap-1 experiments, T7 RNA polymerase transcripts
were made in the absence of cap-analog. These uncapped RNA leaders
were subsequently provided cap-0 or cap-1 structures by using the
ScriptCap™m7G Capping System (EPICENTRE Biotechnologies) in the
25C. Geerts-Dimitriadou et al. / Virology 409 (2011) 17–26absence or presence of the ScriptCap™ 2′-O-Methyltransferase
according to the manufacturer's instruction.
Prior to transcription each DNA template was linearized with
EcoRI. T7 promoter sequences were introduced upstream of the
AlMV3 leader by PCR ampliﬁcation in order to allow in vitro synthesis
of capped leaders.
In vitro inﬂuenza transcription and AlMV3 leader competition assays
In vitro inﬂuenza transcription assays were performed using
approximately 10 μg of puriﬁed inﬂuenza virus particles in a ﬁnal
volume of 25 μl (Fig. 2A). Assays were done according to van
Knippenberg et al. (2002). These assays contained 4 mM Mg acetate,
1 mM of each NTP, 0.1% NP-40, 0.8 U/μl RNasin, 2.5 μl translation mix
(amino acid mixture of 1:1:1 -cys; -lys; -met), and were supplemen-
ted by the AP-Biotech RRL system (GE Healthcare) according to the
manufacturer's procedures. For visualization of the RNA products,
1 mM of [α-32P]CTP (800 Ci/mmol) was added instead of CTP. The
amount of AlMV3 leaders added to the reactions is indicated in the
text and tables. After incubation for 2 h at 37 °C, the reaction mixture
was extracted with phenol–chloroform and the RNA ethanol
precipitated. Radiolabeled RNA products were resolved by electro-
phoresis in a 1% denaturing agarose gel and subsequently transferred
onto Hybond-Nmembrane using the TurboBlotter System (Schleicher
& Schuell). Radiolabeled RNA synthesized was visualized by exposure
of the membrane to autoradiographic ﬁlm.
Analyses of AlMV3-inﬂuenza mRNA sequences
Reverse Transcriptase (RT) PCR ampliﬁcation of de novo synthe-
sized Inﬂuenza NP or NS1 mRNAs containing capped 5′ sequences
derived from AlMV3 was achieved by a strategy during which a
known sequence was efﬁciently incorporated at the end of the cDNA
during ﬁrst strand synthesis, without adaptor ligation (Fig. 2)
(Schmidt and Mueller, 1999; Schramm et al., 2000). In brief, ﬁrst-
strand cDNA was synthesized using an internal primer for the
Inﬂuenza NP or NS1 gene (NPUP1 or NS1UP1 respectively) and in
the presence of a template-switch oligonucleotide (TS-oligo)
(Fig. 2B). Once Superscript II RT reached the 5′ end of the mRNA, its
terminal transferase activity attached several C-residues onto the
newly synthesized strand of cDNA. Subsequently, the TS-oligo,
containing a terminal stretch of G residues paired with the extended
ﬁrst strand cDNA tail and served as an extended template for RT to
switch to. As a result, the template switch approach resulted in a DNA
copy of the entire 5′ leader sequence of viral transcripts ﬂanked by the
TS-oligo sequence. Final PCR ampliﬁcation of the ﬁrst-strand cDNA
involved a nested NP or NS1 primer (primer NPUP2 or NS1UP2
respectively), and a primermatching the TS-oligo and the ﬁrst 11 nt of
the α-globin mRNA leader sequence (primer α-globin), the ﬁrst 6 nt
identical in both α- and β-globin mRNA leader sequence (primer α-/
β-globin), or the AlMV3 leader sequence (primer AlMV3-leader1). In
the case of the leader length requirements experiment, primer
AlMV3-leader2 was used instead of primer AlMV3-leader1 during
the PCR ampliﬁcation.
PCR products of expected size were puriﬁed from a 1% agarose gel
using the GFX PCR puriﬁcation kit (Roche) and cloned into pGEM-T
Easy (Promega) according to the manufacturer's procedures, prior to
sequence analysis by the dideoxynucleotide chain termination
method (Sanger et al., 1977) using standard T7 sequencing primer
and ABI Prism 3700 sequencer (Greenomics™).
Primer sequences are listed in Supplementary Table 1.
Two-step quantitative real-time PCR analysis
De novo synthesized NS1 transcripts were reverse transcribed into
cDNA as described earlier. Afterwards, the ﬁrst-strand cDNA wasapplied in a SYBR Green 1-based quantitative real-time PCR according
to Zwart et al. (2008), with minor modiﬁcations: an annealing
temperature of 50 °C was used and template concentrations were
determined using the standard curve method (RotorGene 6.0
software, Corbett Research). Template cDNA was diluted 500-fold. A
PCR reaction was performed with the AlMV3-leader1 and NS1UP2
primers to determine the AlMV3-NS1 cDNA concentration in the
sample. A separate PCR reactionwas performedwith theα-globin and
NS1UP2 primers to determine the α-globin-NS1 cDNA concentration.
The AlMV3-NS1/α-globin-NS1 ratio was determined for each pair of
replicates, and three replicates were performed in total. The
geometric mean and standard error of mean of the AlMV3-NS1/α-
globin-NS1 ratio were then calculated. All further statistical analysis
was performed in SPSS 15.0 (SPSS Inc., Chicago, IL).
Supplementarymaterials related to this article can be found online
at doi:10.1016/j.virol.2010.09.003.Acknowledgments
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